Principal Financial Group Inc. Reduces Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Principal Financial Group Inc. lowered its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 4.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,123 shares of the company’s stock after selling 2,417 shares during the period. Principal Financial Group Inc.’s holdings in USANA Health Sciences were worth $1,977,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. BOKF NA raised its position in shares of USANA Health Sciences by 274.5% during the 1st quarter. BOKF NA now owns 2,771 shares of the company’s stock worth $133,000 after purchasing an additional 2,031 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in USANA Health Sciences by 9.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock worth $284,000 after buying an additional 494 shares in the last quarter. Exchange Traded Concepts LLC raised its holdings in shares of USANA Health Sciences by 4.4% in the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock worth $292,000 after acquiring an additional 322 shares during the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of USANA Health Sciences by 44.1% during the third quarter. Harbor Capital Advisors Inc. now owns 8,859 shares of the company’s stock valued at $336,000 after acquiring an additional 2,713 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in USANA Health Sciences during the 2nd quarter worth about $340,000. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Separately, DA Davidson decreased their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 23rd.

USANA Health Sciences Stock Performance

Shares of USNA opened at $39.90 on Friday. USANA Health Sciences, Inc. has a fifty-two week low of $34.15 and a fifty-two week high of $54.81. The company has a market capitalization of $760.49 million, a PE ratio of 14.08, a price-to-earnings-growth ratio of 1.33 and a beta of 0.89. The stock has a fifty day moving average of $37.80 and a two-hundred day moving average of $41.77.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The firm had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. During the same period in the prior year, the firm posted $0.59 earnings per share. As a group, equities research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.